Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Anti Ageing Drugs Companies

Anti-aging drug companies focus on developing pharmaceuticals and medical interventions that aim to slow down the aging process, extend lifespan, and enhance the quality of life in later years. While the concept of anti-aging drugs is still a topic of ongoing research and debate, several companies are actively engaged in this field.

*Disclaimer: List of key companies in no particular orderLatest Anti-aging drug Companies Update

Aug 2023: The XEOMIN (incobotulinumtoxinA) drug from Merz Therapeutics has been permitted a new indication by the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) to treat focal spasticity of the lower limbs that affects the ankle joint. The procedure was previously authorized in the UK to treat spasticity in the upper limbs. Thanks to the increased permission, the company can now offer comprehensive care to anyone with spasticity who requires it. IncobotulinumtoxinA is the active component of XEOMIN. To increase muscle tone, it is intramuscularly administered. Therapy reduces the strength of voluntary muscular contraction by blocking nerve signals to the muscles. It reduces aberrant muscular tone by preventing the release of acetylcholine from peripheral nerve terminals. According to Merz Therapeutics, XEOMIN is now suitable to treat the lower and upper limbs separately by adjusting the dose as required.

Sep 2023: Procter & Gamble India, a manufacturer of FMCG products, on Thursday unveiled a Rs 300 crore fund to work with outside partners and innovators to co-create solutions for a contemporary supply chain ecosystem. According to a statement from the company, the P&G Supply Chain Catalyst Fund would give startups and innovators the chance to work with Procter & Gamble (P&G) India on tailoring business solutions, speeding its progress towards Supply 3.0 ambitions. This is a portion of the Rs 1,800 crore dedicated to business solutions via vGROW, in which the company that makes products under the Gillette, Whisper, and Vicks brands invests in startups, established companies, and people and groups offering cutting-edge solutions.

List of Anti-aging drug Key companies in the market

Merz Pharma (Germany)

Procter & Gamble (US)

Nu Skin (US)

BIOTIME Inc (US)

Elysium Health Inc (US)

La Roche-Posay (UK)

DermaFix (South Africa)

L’Oreal (France)

Estee Lauder Inc. (US)

Oriflame Cosmetics (Switzerland)

Anti Ageing Drugs Market Highlights:

Anti Ageing Drugs Market Size

Anti Ageing Drugs Market Trends

Anti Ageing Drugs Market Analysis

Anti Ageing Drugs Market Share

Anti Ageing Drugs Market Highlights:

Anti Ageing Drugs Market Trends

Anti Ageing Drugs Market Analysis

Anti Ageing Drugs Market Share

Anti Ageing Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.